Psychedelics at AAAP 37th Annual Meeting and Scientific Symposium
6 sessions on psychedelics · November 12–15, 2026, Memphis, TN. Compare psychedelics at other meetings →
Sunday, November 15
Posters (6)
- Feasibility of Multimodal In Vivo Assessment of Psilocybin in Opioid Use Disorder: A Case Series — Julia Shatalov
- Hallucinogen Persisting Perception Disorder In An Adolescent: A Case Report — Phil Dohn
- Psilocybin Use, Mental Health Treatment Utilization, and Unmet Treatment Need Among US Individuals with Depression — Avery Eun
- Virtual Reality-Based Psychedelic-Like Perceptual Alterations — Yalda Farahmand
- Supplementary Pathway for Medically Monitored Ibogaine for Opioid Use Disorder: A National Semi-Markov Cost-Effectiveness Analysis — T Wagner
- Psychiatric Destabilization following Bufo (5-MeO-DMT) Exposure in a Patient with Pre-Existing PTSD: A Case Report — Sabrina Chen
Other topics at this meeting
Substance Use Disorders 87Opioid Use Disorder 48Cannabis & Cannabinoids 17Alcohol Use Disorder 16Child & Adolescent 14Drug Interactions & Safety 13Education & Training 12Schizophrenia & Psychosis 12Emergency & Acute Psychiatry 11Digital Psychiatry & AI 8Practice, Policy & Workforce 8PTSD & Trauma 8